Description

In 2016, Health Canada reviewed the risk of gadolinium build-up in the brain and potential neurological side effects in light of published studies showing that gadolinium may accumulate in the brain when GBCAs are given repeatedly. The neurological effects of these build-ups are not known.

Resources

Name	Format	Description	Link
Summary Safety Review - Gadolinium based contrast agents - Assessing the risk of gadolinium build-up in the brain and potential brain and nervous system (neurological) side effects	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/gadolinium-based-contrast-agents-assessing-risk-build-up-in-brain-and-potential-brain-nervous-system-side-effects.html
Summary Safety Review - Gadolinium based contrast agents - Assessing the risk of gadolinium build-up in the brain and potential brain and nervous system (neurological) side effects	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/agents-contraste-base-gadolinium-evaluation-risques-depots-dans-cerveau-et-effets-secondaires-potentiels-cerveau-systeme-nerveux.html

Tags

Topics

Categories